Decreased levels of amyloid-β 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients

Journal of Alzheimer's Disease

Volumn 1, Issue 6, 1999, Pages 419-424

  Van Everbroeck, B ^a   Green, A J E ^a   Pals, Ph ^a   Martin, J J ^a   Cras, P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

14 3 3; Alzheimer's disease; Amyloid; Dementia; ELISA; hTau protein

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0033296828     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-1606     Document Type: Article

References (30)

1. Cerebrospinal fluid beta-amyloid 1-42 in Alzheimer disease: Differences between early- and late onset AD and stability during course of the disease
2. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
3. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease
4. Genetic and physical characterization of the early-onset Alzheimer's disease AD3 locus on chromosome 14q24.3
5. The presenilin genes: A new gene family involved in Alzheimer disease pathology
6. Alzheimer's disease and Creutzfeldt-Jakob disease: Overlap of pathogenic mechanisms
7. Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease
8. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
9. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
10. Increased cerebrospinal fluid hTau in patients with Alzheimer's disease
11. Water soluble Abeta (N-40, N-42) oligomers in normal and AD brains
12. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease
13. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
14. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Services Task Force on Alzheimer's disease
15. Reduction of beta-amyloid in the cerebrospinal fluid of patients with Alzheimer's disease
16. Elevated levels of hTau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
17. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
18. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: Alterations in normal aging and in Alzheimer's disease
19. Novel proteinaceous infectious particles cause scrapie
20. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease
21. Detection of hTau-proteins in normal and AD cerebrospinal fluid with a sensitive sandwich enzyme linked immunosorbent assay
22. Retrospective study of Creutzfeldt-Jakob's disease in Belgium: Neuropathological findings
23. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies
24. Epidemiology of Creutzfeldt-Jakob disease
25. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease
26. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid
27. The 14-3-3 brain protein and transmissible spongiform encephalopathy
28. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease